Evidence map›Paper›PMID 40684072›Full record

ReviewPulmonary therapy2025

Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper.

Abdullah Shehab, Huda Al Dhanhani, Omar Alhammadi, Mohamed Badi Hassan, Mohamed Farghaly, Ahmed Hassoun, Bassam Mahboub, Mona Tahlak, Reem Faisal Abutayeh, Hammam Haridy and 3 more

Abstract readReview
In one paragraph

Review in Pulmonary therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Abdullah ShehabDepartment of Interventional Cardiology, Burjeel Royal and Mediclinic Hospitals, Al Ain, UAE. heartdr123@googlemail.com.ORCID http://orcid.org/0000-0001-8533-9174
Huda Al DhanhaniSheikh Khalifa Medical City, Abu Dhabi, UAE.
Omar AlhammadiAl-Dhannah Hospital, Abu Dhabi, UAE.
Mohamed Badi HassanMinistry of Health and Prevention, Dubai, UAE.
Mohamed FarghalyUnited Medical Centre, Dubai, UAE.
Ahmed HassounFakeeh University Hospital, Dubai, UAE.
Bassam MahboubRashid Hospital, Dubai, UAE.
Mona TahlakLatifa Hospital, Dubai, UAE.
Reem Faisal AbutayehPfizer Gulf FZ LLC, Dubai, UAE.
Hammam HaridyPfizer Gulf FZ LLC, Dubai, UAE.
Ashraf HassanienPfizer Saudi Limited, Jeddah, Saudi Arabia.
Jean JouryPfizer Gulf FZ LLC, Dubai, UAE.
Humaid O Al-ShamsiBurjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, UAE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory infections are a major cause of mortality among young children and adults, particularly the elderly or those with underlying medical conditions. Many respiratory infections, including influenza, COVID-19, pneumococcal disease, and respiratory syncytial virus (RSV), have available vaccines and antiviral agents. However, vaccine coverage rates remain low. Experts representing a broad spectrum of medical specialties from the United Arab Emirates (UAE) made evidence-based recommendations on treating patients considered high risk for respiratory infections, highlighting gaps in current practices and suggesting strategies for improved communication between healthcare professionals and patients. To effectively manage respiratory infections, the experts emphasized the importance of adhering to guidelines, considering all vaccines and antiviral treatments, and strictly following vaccination schedules. Early testing upon recognition of symptoms was also encouraged. Improving vaccine uptake was considered crucial and could be achieved by educating patients about disease prevention through vaccines and the role of antiviral treatments for COVID-19. Addressing knowledge gaps and combating vaccine hesitancy among both patients and healthcare professionals were also essential steps. Recommendations for future initiatives include healthcare professionals educating the public on precautionary measures to reduce the spread of respiratory infections. Additionally, the experts agreed that clinical management guidelines for chronic diseases should be updated to include preventative strategies such as vaccines, prophylaxis, and counselling. Monitoring the performance of healthcare facilities using key performance indicators is also recommended to ensure effective management and continuous improvement of vaccination programs. Patient populations in the UAE who are considered at high risk of serious disease from respiratory infections have diverse medical needs and may access healthcare across a wide range of settings and specialisms. Therefore, it is vital that all healthcare professionals across specialisms who may engage with these individuals are able to provide appropriate advice on managing the risk through vaccination, prompt testing, and treatments as needed.

Indexed as

Antiviral agentsCOVID-19InfluenzaManagementPneumococcal infectionsPreventionRespiratory syncytial virusVaccines

Identifiers

PMID40684072
PMCPMC12373577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.